deltatrials
Recruiting EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02823665

The Effects of Bariatric Surgeries on Glucose Metabolism

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions Gastric Bypass Hypoglycemia After Gastric Bypass Post Bariatric Surgery Sleeve Gastrectomy
Interventions Atropine Exendin-(9-39)
Updated 17 times since 2017 Last updated: Sep 8, 2025 Started: Jul 31, 2015 Primary completion: Aug 31, 2026 Completion: Aug 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02823665, this EARLY_PHASE1 trial focuses on Gastric Bypass and Hypoglycemia After Gastric Bypass and remains actively recruiting participants. Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it has been updated 17 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshot~Oct 2017 – ~May 2018 · 7 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshot~Jun 2019 – ~Jun 2020 · 12 months · monthly snapshot~Jun 2020 – ~Sep 2020 · 3 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Sep 2022 · 11 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Sep 2023 · 9 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – ~Oct 2025 · 7 months · monthly snapshot~Oct 2025 – present · 9 months · monthly snapshot

Change History

17 versions recorded

  1. Oct 2025 — Present [monthly]

    Recruiting EARLY_PHASE1

  2. Mar 2025 — Oct 2025 [monthly]

    Recruiting EARLY_PHASE1

  3. Sep 2024 — Mar 2025 [monthly]

    Recruiting EARLY_PHASE1

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting EARLY_PHASE1

  5. Sep 2023 — Jul 2024 [monthly]

    Recruiting EARLY_PHASE1

▶ Show 12 earlier versions

  1. Dec 2022 — Sep 2023 [monthly]

    Recruiting EARLY_PHASE1

  2. Sep 2022 — Dec 2022 [monthly]

    Recruiting EARLY_PHASE1

  3. Oct 2021 — Sep 2022 [monthly]

    Recruiting EARLY_PHASE1

  4. Jan 2021 — Oct 2021 [monthly]

    Recruiting EARLY_PHASE1

  5. Sep 2020 — Jan 2021 [monthly]

    Recruiting EARLY_PHASE1

  6. Jun 2020 — Sep 2020 [monthly]

    Recruiting EARLY_PHASE1

  7. Jun 2019 — Jun 2020 [monthly]

    Recruiting EARLY_PHASE1

  8. Jun 2018 — Jun 2019 [monthly]

    Recruiting EARLY_PHASE1

    Status: Suspended → Recruiting

  9. May 2018 — Jun 2018 [monthly]

    Suspended EARLY_PHASE1

  10. Oct 2017 — May 2018 [monthly]

    Suspended EARLY_PHASE1

    Status: Recruiting → Suspended

  11. Feb 2017 — Oct 2017 [monthly]

    Recruiting EARLY_PHASE1

    Phase: Phase 0 → EARLY_PHASE1

  12. Jan 2017 — Feb 2017 [monthly]

    Recruiting Phase 0

    First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • The University of Texas Health Science Center at San Antonio
Data source: The University of Texas Health Science Center at San Antonio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations